ENVISTA ASPIRE Trademark

Trademark Overview

On Thursday, February 17, 2022, a trademark application was filed for ENVISTA ASPIRE with the United States Patent and Trademark Office. The USPTO has given the ENVISTA ASPIRE trademark a serial number of 97271737. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by Bausch & Lomb Incorporated. The ENVISTA ASPIRE trademark is filed in the Medical Instrument Products category with the following description:

Intraocular lenses; Intraocular prostheses in the nature of lenses for surgical implantation
envista aspire

General Information

Serial Number97271737
Word MarkENVISTA ASPIRE
Filing DateThursday, February 17, 2022
Status700 - REGISTERED
Status DateTuesday, July 30, 2024
Registration Number7463940
Registration DateTuesday, July 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesIntraocular lenses; Intraocular prostheses in the nature of lenses for surgical implantation

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code010
First Use Anywhere DateTuesday, October 24, 2023
First Use In Commerce DateWednesday, December 6, 2023

Trademark Owner History

Party NameBausch & Lomb Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRochester, NY 14609
Party NameBausch & Lomb Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRochester, NY 14609
Party NameBausch & Lomb Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRochester, NY 14609

Trademark Events

Event DateEvent Description
Wednesday, June 22, 2022LETTER OF SUSPENSION E-MAILED
Monday, February 21, 2022NEW APPLICATION ENTERED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022SUSPENSION LETTER WRITTEN
Wednesday, June 22, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 10, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 10, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 6, 2023SOU EXTENSION 1 FILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 1 GRANTED
Saturday, April 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2024USE AMENDMENT FILED
Saturday, April 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, March 25, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, June 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 27, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

aspire envista intraocular lenses implantation surgical prostheses nature